Abstract

The purpose: to determine the place of progressive spectacles correction in an integrated approach for the treatment of early stages of age-related macular degeneration (AMD) in hyperopic patients. Material and methods: 30 patients (60 eyes) aged 42-75 y.o., average age (58,8 ± 6,5) years, with early stages of AMD and hyperopia were under observation. The observation group was represented by 20 patients (40 eyes). After AMD revealing they applied progressive spectacles correction of «universal» type and received orally dietary supplement Retinorm® 3 capsules one time per day. The comparison group consisted of 10 patients (20 eyes). They received the same oral dietary supplement and used the previous monofocal correction. Methods of examination of patients included: checking of visual acuity with correction, refractometry, tonometry, computer static perimetry, ophthalmobiomicroscopy with Goldmann lens, optical coherence tomography of the central fundus area with measurement of retinal thickness in the fovea zone and choroid in manual mode. The duration of observation in both groups was 4 months. Results. The thickness of the retina in the fovea zone after the use of correction and prescribed treatment did not change either in the observation group (p > 0,1) or in the comparison group (p > 0,1). The thickness of the choroid after the prescribed therapeutic measures significantly increased in the observation group (p < 0,05) and remained without changes in the comparison group (p > 0,1). An increase of visual acuity was established, as well as a decrease in the number of relative scotomas in the central part of the visual field both in the observation group (p < 0,02) and in the comparison group (p < 0,05). Conclusion. The use of «universal» type of progressive spectacles correction in combination with taking dietary supplement Retinorm® increases the effectiveness of treatment of early stages of AMD in hyperopic patients due to both the activation of choroidal blood circulation, and the improvement of metabolic processes in the choroid and retina.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.